UnitedHealth Group Inc has a consensus price target of $599.07 based on the ratings of 29 analysts. The high is $680 issued by UBS on July 18, 2024. The low is $460 issued by HSBC on April 4, 2024. The 3 most-recent analyst ratings were released by UBS, Argus Research, and TD Cowen on July 18, 2024, July 17, 2024, and July 17, 2024, respectively. With an average price target of $627 between UBS, Argus Research, and TD Cowen, there's an implied 12.26% upside for UnitedHealth Group Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/18/2024 | Buy Now | 21.75% | UBS | Kevin Caliendo | $640 → $680 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 7.42% | Argus Research | David Toung | $570 → $600 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 7.6% | TD Cowen | Gary Taylor | $546 → $601 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 8.14% | Barclays | Andrew Mok | $560 → $604 | Maintains | Overweight | Get Alert |
07/17/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
07/17/2024 | Buy Now | 12.8% | Wells Fargo | Stephen Baxter | $525 → $630 | Maintains | Overweight | Get Alert |
07/17/2024 | Buy Now | 14.59% | Truist Securities | David Macdonald | $600 → $640 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 10.11% | RBC Capital | Ben Hendrix | $555 → $615 | Maintains | Outperform | Get Alert |
07/17/2024 | Buy Now | 15.84% | Jefferies | David Windley | $481 → $647 | Upgrade | Hold → Buy | Get Alert |
07/17/2024 | Buy Now | 14.59% | Baird | Michael Ha | $597 → $640 | Maintains | Outperform | Get Alert |
07/17/2024 | Buy Now | 10.11% | Morgan Stanley | Ricky Goldwasser | $595 → $615 | Maintains | Overweight | Get Alert |
07/09/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
06/12/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
05/30/2024 | Buy Now | 0.08% | JP Morgan | Lisa Gill | $546 → $559 | Maintains | Overweight | Get Alert |
05/30/2024 | Buy Now | 6.89% | Baird | Michael Ha | → $597 | Initiates | → Outperform | Get Alert |
04/19/2024 | Buy Now | 0.62% | Deutsche Bank | George Hill | $545 → $562 | Maintains | Buy | Get Alert |
04/17/2024 | Buy Now | 7.42% | Truist Securities | David Macdonald | → $600 | Reiterates | Buy → Buy | Get Alert |
04/17/2024 | Buy Now | -0.63% | RBC Capital | Ben Hendrix | $596 → $555 | Maintains | Outperform | Get Alert |
04/17/2024 | Buy Now | 0.26% | Barclays | Andrew Mok | $534 → $560 | Maintains | Overweight | Get Alert |
04/17/2024 | Buy Now | 2.23% | Piper Sandler | Jessica Tassan | $566 → $571 | Maintains | Overweight | Get Alert |
04/10/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
04/10/2024 | Buy Now | -2.24% | TD Cowen | Gary Taylor | $607 → $546 | Maintains | Buy | Get Alert |
04/08/2024 | Buy Now | -6% | Wells Fargo | Stephen Baxter | $600 → $525 | Maintains | Overweight | Get Alert |
04/05/2024 | Buy Now | 4.56% | Morgan Stanley | Ricky Goldwasser | $618 → $584 | Maintains | Overweight | Get Alert |
04/04/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
04/04/2024 | Buy Now | -17.64% | HSBC | Rajesh Kumar | → $460 | Upgrade | Reduce → Hold | Get Alert |
03/13/2024 | Buy Now | — | Erste Group | Hans Engel | — | Downgrade | Buy → Hold | Get Alert |
03/07/2024 | Buy Now | 20.85% | B of A Securities | Kevin Fischbeck | $675 → $675 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | -1.35% | Barclays | Andrew Mok | → $551 | Initiates | → Overweight | Get Alert |
02/29/2024 | Buy Now | 6.71% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
02/08/2024 | Buy Now | 8.32% | Stephens & Co. | Scott Fidel | → $605 | Reiterates | Overweight → Overweight | Get Alert |
01/19/2024 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
01/17/2024 | Buy Now | 9.22% | Oppenheimer | Michael Wiederhorn | → $610 | Reiterates | Outperform → Outperform | Get Alert |
01/17/2024 | Buy Now | 4.02% | Piper Sandler | Jessica Tassan | $584 → $581 | Maintains | Overweight | Get Alert |
01/16/2024 | Buy Now | 8.32% | Stephens & Co. | Scott Fidel | $615 → $605 | Maintains | Overweight | Get Alert |
01/16/2024 | Buy Now | 6.71% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
12/18/2023 | Buy Now | -14.06% | HSBC | Rajesh Kumar | $550 → $480 | Downgrade | Hold → Reduce | Get Alert |
12/13/2023 | Buy Now | 4.74% | Stephens & Co. | Scott Fidel | → $585 | Reiterates | Overweight → Overweight | Get Alert |
11/30/2023 | Buy Now | 9.22% | Truist Securities | David Macdonald | → $610 | Reiterates | Buy → Buy | Get Alert |
11/30/2023 | Buy Now | 6.71% | RBC Capital | Ben Hendrix | → $596 | Reiterates | Outperform → Outperform | Get Alert |
11/30/2023 | Buy Now | 4.74% | Stephens & Co. | Scott Fidel | → $585 | Reiterates | Overweight → Overweight | Get Alert |
11/21/2023 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
11/20/2023 | Buy Now | -9.94% | Jefferies | David Windley | $565 → $503 | Maintains | Hold | Get Alert |
10/23/2023 | Buy Now | 3.66% | Morgan Stanley | Ricky Goldwasser | $587 → $579 | Maintains | Overweight | Get Alert |
10/16/2023 | Buy Now | 6.71% | RBC Capital | Ben Hendrix | $572 → $596 | Maintains | Outperform | Get Alert |
10/16/2023 | Buy Now | 4.56% | Piper Sandler | Jessica Tassan | $580 → $584 | Maintains | Overweight | Get Alert |
10/16/2023 | Buy Now | 14.59% | UBS | Kevin Caliendo | → $640 | Upgrade | Neutral → Buy | Get Alert |
10/09/2023 | Buy Now | -4.93% | Jefferies | David Windley | $529 → $531 | Maintains | Hold | Get Alert |
09/14/2023 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Reiterates | Overweight → Overweight | Get Alert |
09/06/2023 | Buy Now | -3.32% | HSBC | Morten Herholdt | → $540 | Initiates | → Hold | Get Alert |
08/11/2023 | Buy Now | 0.26% | Stephens & Co. | Scott Fidel | → $560 | Reiterates | Overweight → Overweight | Get Alert |
07/19/2023 | Buy Now | -6.9% | UBS | Kevin Caliendo | $510 → $520 | Maintains | Neutral | Get Alert |
07/18/2023 | Buy Now | 7.96% | Bernstein | Lance Wilkes | $595 → $603 | Upgrade | Market Perform → Outperform | Get Alert |
07/17/2023 | Buy Now | -0.63% | Deutsche Bank | George Hill | $564 → $555 | Maintains | Buy | Get Alert |
07/17/2023 | Buy Now | 2.41% | RBC Capital | Ben Hendrix | $592 → $572 | Maintains | Outperform | Get Alert |
07/17/2023 | Buy Now | 9.22% | Oppenheimer | Michael Wiederhorn | → $610 | Reiterates | Outperform → Outperform | Get Alert |
07/14/2023 | Buy Now | 16.38% | B of A Securities | Kevin Fischbeck | $650 → $650 | Maintains | Buy | Get Alert |
07/14/2023 | Buy Now | 5.1% | Morgan Stanley | Erin Wright | $587 → $587 | Reiterates | Overweight → Overweight | Get Alert |
07/13/2023 | Buy Now | -8.69% | UBS | Kevin Caliendo | $550 → $510 | Maintains | Neutral | Get Alert |
07/13/2023 | Buy Now | 0.44% | Wells Fargo | Stephen Baxter | $616 → $561 | Maintains | Overweight | Get Alert |
07/12/2023 | Buy Now | -6.36% | Jefferies | David Windley | $524 → $523 | Maintains | Hold | Get Alert |
07/11/2023 | Buy Now | -1.71% | Mizuho | Ann Hynes | $600 → $549 | Maintains | Buy | Get Alert |
07/07/2023 | Buy Now | -5.65% | JP Morgan | Lisa Gill | $562 → $527 | Maintains | Overweight | Get Alert |
06/27/2023 | Buy Now | 3.84% | Truist Securities | David Macdonald | → $580 | Reiterates | Buy → Buy | Get Alert |
06/16/2023 | Buy Now | 0.98% | Deutsche Bank | George Hill | $627 → $564 | Maintains | Buy | Get Alert |
06/16/2023 | Buy Now | 9.22% | Oppenheimer | Michael Wiederhorn | → $610 | Reiterates | Outperform → Outperform | Get Alert |
06/14/2023 | Buy Now | 1.16% | Bernstein | Lance Wilkes | → $565 | Maintains | Market Perform | Get Alert |
06/14/2023 | Buy Now | 0.26% | SVB Securities | Whit Mayo | $625 → $560 | Maintains | Outperform | Get Alert |
06/14/2023 | Buy Now | 3.84% | Truist Securities | David Macdonald | $610 → $580 | Maintains | Buy | Get Alert |
06/14/2023 | Buy Now | 7.42% | Mizuho | Ann Hynes | → $600 | Reiterates | Buy → Buy | Get Alert |
06/14/2023 | Buy Now | 5.99% | RBC Capital | Ben Hendrix | → $592 | Reiterates | Outperform → Outperform | Get Alert |
05/30/2023 | Buy Now | 0.62% | JP Morgan | Lisa Gill | $595 → $562 | Maintains | Overweight | Get Alert |
05/26/2023 | Buy Now | 3.84% | Piper Sandler | Jessica Tassan | → $580 | Initiates | → Overweight | Get Alert |
05/23/2023 | Buy Now | 11.9% | SVB Securities | Whit Mayo | $625 → $625 | Maintains | Outperform | Get Alert |
05/11/2023 | Buy Now | 16.38% | B of A Securities | Kevin Fischbeck | $650 → $650 | Maintains | Buy | Get Alert |
04/21/2023 | Buy Now | 5.81% | Cantor Fitzgerald | Sarah James | → $591 | Initiates | → Overweight | Get Alert |
04/18/2023 | Buy Now | -6.18% | Jefferies | David Windley | $531 → $524 | Maintains | Hold | Get Alert |
04/17/2023 | Buy Now | 16.38% | B of A Securities | Kevin Fischbeck | $650 → $650 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 12.26% | Deutsche Bank | George Hill | $617 → $627 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 11.9% | SVB Securities | Whit Mayo | $625 → $625 | Maintains | Outperform | Get Alert |
04/17/2023 | Buy Now | 12.8% | Raymond James | John Ransom | → $630 | Maintains | Strong Buy | Get Alert |
04/17/2023 | Buy Now | 0.62% | TD Cowen | Gary Taylor | $596 → $562 | Maintains | Outperform | Get Alert |
04/17/2023 | Buy Now | 7.42% | Loop Capital | Joseph France | $590 → $600 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 9.22% | Oppenheimer | Michael Wiederhorn | → $610 | Reiterates | → Outperform | Get Alert |
04/17/2023 | Buy Now | 5.99% | RBC Capital | Ben Hendrix | → $592 | Reiterates | → Outperform | Get Alert |
04/14/2023 | Buy Now | 1.16% | Barclays | Steven Valiquette | $565 → $565 | Maintains | Overweight | Get Alert |
04/14/2023 | Buy Now | 12.8% | Raymond James | John Ransom | → $630 | Maintains | Strong Buy | Get Alert |
04/06/2023 | Buy Now | 5.1% | Morgan Stanley | Erin Wright | $587 → $587 | Maintains | Overweight | Get Alert |
04/05/2023 | Buy Now | 12.8% | Raymond James | John Ransom | $615 → $630 | Upgrade | Outperform → Strong Buy | Get Alert |
03/07/2023 | Buy Now | 16.38% | B of A Securities | Kevin Fischbeck | $650 → $650 | Maintains | Buy | Get Alert |
02/28/2023 | Buy Now | 8.32% | Stephens & Co. | Scott Fidel | → $605 | Reiterates | → Overweight | Get Alert |
01/24/2023 | Buy Now | 10.47% | Deutsche Bank | George Hill | $615 → $617 | Maintains | Buy | Get Alert |
01/18/2023 | Buy Now | -1.53% | UBS | Kevin Caliendo | $590 → $550 | Maintains | Neutral | Get Alert |
01/17/2023 | Buy Now | 5.63% | Loop Capital | Joseph France | $575 → $590 | Maintains | Buy | Get Alert |
01/17/2023 | Buy Now | 11.9% | SVB Securities | Whit Mayo | → $625 | Maintains | Outperform | Get Alert |
01/17/2023 | Buy Now | 11.9% | SVB Leerink | Whit Mayo | $618 → $625 | Maintains | Outperform | Get Alert |
12/13/2022 | Buy Now | 16.38% | B of A Securities | Kevin Fischbeck | $632 → $650 | Maintains | Buy | Get Alert |
12/07/2022 | Buy Now | 9.22% | Credit Suisse | A.J. Rice | $590 → $610 | Maintains | Outperform | Get Alert |
11/30/2022 | Buy Now | 10.65% | SVB Securities | Whit Mayo | → $618 | Maintains | Outperform | Get Alert |
11/23/2022 | Buy Now | 5.1% | Morgan Stanley | Erin Wright | → $587 | Assumes | → Overweight | Get Alert |
The latest price target for UnitedHealth Group (NYSE:UNH) was reported by UBS on July 18, 2024. The analyst firm set a price target for $680.00 expecting UNH to rise to within 12 months (a possible 21.75% upside). 51 analyst firms have reported ratings in the last year.
The latest analyst rating for UnitedHealth Group (NYSE:UNH) was provided by UBS, and UnitedHealth Group maintained their buy rating.
The last upgrade for UnitedHealth Group Inc happened on July 17, 2024 when Jefferies raised their price target to $647. Jefferies previously had a hold for UnitedHealth Group Inc.
The last downgrade for UnitedHealth Group Inc happened on March 13, 2024 when Erste Group changed their price target from N/A to N/A for UnitedHealth Group Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UnitedHealth Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UnitedHealth Group was filed on July 18, 2024 so you should expect the next rating to be made available sometime around July 18, 2025.
While ratings are subjective and will change, the latest UnitedHealth Group (UNH) rating was a maintained with a price target of $640.00 to $680.00. The current price UnitedHealth Group (UNH) is trading at is $558.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.